Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 47.29 Yuan From 50.75 Yuan, Keeps at Neutral

MT NewswiresAug 29 05:37 ET · Ratings

Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$28.56 From HK$30.65, Keeps at Neutral

MT NewswiresAug 29 05:37 ET · Ratings

Hangzhou Tigermed Consulting's H1 Profit Falls 65%

MT NewswiresAug 29 03:10 ET

Tiger Pharmaceuticals: 2024 Semi-Annual Report Summary

SZSIAug 28 12:00 ET · Announcements

Tiger Pharmaceuticals: Semi-Annual Report 2024

SZSIAug 28 12:00 ET · Announcements

Tigermed Reallocates IPO Funds for Expansion and Tech

TipRanksAug 28 07:08 ET